Vasostatins: new molecular targets for atherosclerosis, post-ischaemic angiogenesis, and arteriogenesis

Cardiovasc Res. 2024 Mar 13;120(2):132-139. doi: 10.1093/cvr/cvae008.

Abstract

The chromogranin-secretogranin secretory proteins-granins-are acidic proteins localized in granules of endocrine cells and neurons. The chromogranin family includes chromogranins A (CgA) and B, as well as secretogranin II (once called chromogranin C). Members of this family undergo catalytic proteolysis to produce active peptides. The CgA-derived peptides vasostatin-1 and vasostatin-2, in particular, appear to protect against atherosclerosis, suppressing the expression of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, as well as exerting vasodilatory effects by enhancing nitric oxide bioavailability. Vasostatin-1 also suppresses vasoconstriction and abnormal angiogenesis. Vasostatin-1 and vasostatin-2 may be novel therapeutic targets for atherosclerosis and coronary heart disease, also protecting the myocardium against ischaemic damage.

Keywords: Angiogenesis; Arteriogenesis; Atherosclerosis; Chromogranins; Vasostatins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis
  • Atherosclerosis*
  • Calreticulin*
  • Chromogranins* / chemistry
  • Chromogranins* / metabolism
  • Humans
  • Peptide Fragments*
  • Peptides
  • Proteins / metabolism

Substances

  • Chromogranins
  • vasostatin
  • Proteins
  • Peptides
  • Peptide Fragments
  • Calreticulin